These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15770965)
21. To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease. Growdon JH Ann Neurol; 1998 Jul; 44(1):6-7. PubMed ID: 9667586 [No Abstract] [Full Text] [Related]
22. Cerebrospinal fluid biomarkers in Alzheimer's disease: are the hypotheses more dynamic than the biomarkers? Spies PE; Verbeek MM; Olde Rikkert MG; Claassen JA J Am Geriatr Soc; 2010 Aug; 58(8):1619-20. PubMed ID: 20942893 [No Abstract] [Full Text] [Related]
23. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111 [TBL] [Abstract][Full Text] [Related]
24. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Brew BJ; Pemberton L; Blennow K; Wallin A; Hagberg L Neurology; 2005 Nov; 65(9):1490-2. PubMed ID: 16275845 [TBL] [Abstract][Full Text] [Related]
25. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742 [TBL] [Abstract][Full Text] [Related]
27. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559 [TBL] [Abstract][Full Text] [Related]
28. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42). Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854 [TBL] [Abstract][Full Text] [Related]
29. New tests for AD. Health News; 2006 Apr; 12(4):15. PubMed ID: 16578901 [No Abstract] [Full Text] [Related]
30. [Biomarkers in cerebrospinal fluid and blood in memory complaints]. Zetterberg H; Andreasen N; Blennow K Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836 [No Abstract] [Full Text] [Related]
31. Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties. Marksteiner J; Pirchl M; Ullrich C; Oberbauer H; Blasko I; Lederer W; Hinterhuber H; Humpel C Pharmacology; 2008; 82(3):214-20. PubMed ID: 18810245 [TBL] [Abstract][Full Text] [Related]
32. Alzheimer's biomarker initiative hits its stride. Miller G Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956 [No Abstract] [Full Text] [Related]
33. Elevated CNS concentrations of NFL in idiopathic normal pressure hydrocephalus (INPH) and subcortical arteriosclerotic encephalopathy (SAE). Jellinger KA; Rösler N Acta Neurol Scand; 2008 Jun; 117(6):435. PubMed ID: 18307570 [No Abstract] [Full Text] [Related]
34. Biomarkers in dementia. Vanacore N; Galeotti F; Maggini M; Raschetti R Arch Neurol; 2007 Sep; 64(9):1356; author reply 1357-9. PubMed ID: 17846281 [No Abstract] [Full Text] [Related]
35. The diagnosis of Alzheimer disease before it is Alzheimer dementia. Frisoni GB; Padovani A; Wahlund LO Arch Neurol; 2003 Jul; 60(7):1023; author reply 1023-4. PubMed ID: 12873864 [No Abstract] [Full Text] [Related]
36. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505 [TBL] [Abstract][Full Text] [Related]